MissionIR Articles

  • Information Services Group (III) Presents at Rodman & Renshaw Conference

    Information Services Group, Inc. (NASDAQ: III) is a leading technology insights, market intelligence and advisory services company, serving more than 500 clients around the world to help them achieve operational excellence. ISG supports private and…

  • Immunomedics (IMMU) Presents at Rodman & Renshaw Conference

    Immunomedics, Inc. (NASDAQ: IMMU) is committed to being a leading, innovative biopharmaceutical company dedicated to improving a patient’s health and quality of life with novel antibody–based therapeutics for the treatment of cancer, autoimmune and other…

  • Immune Pharmaceuticals (IMNP) Presents at Rodman & Renshaw Conference

    Immune Pharmaceuticals, Inc. (NASDAQ: IMNP) applies a personalized approach to treatment, developing novel, highly targeted antibody therapeutics to improve the lives of patients with inflammatory diseases and cancer. The company’s lead product candidate, bertilimumab, is…

  • IDI (IDI) Presents at Rodman & Renshaw Conference

    IDI, Inc. (NYSE: IDI) is an information solutions provider focused on the data fusion market. IDI delivers otherwise unattainable insight into the ever-expanding universe of consumer- and business-centric data. Through proprietary linking technology, advanced systems…

  • I.D Systems (IDSY) Presents at Rodman & Renshaw Conference

    I.D. Systems, Inc. (NASDAQ: IDSY) has pioneered the use of RFID (radio frequency identification) technology for wireless vehicle management and fleet tracking. The initial success of I.D. Systems’ emerging technology came in 1995 when the…

  • Hydrogenics (HYGS) Presents at Rodman & Renshaw Conference

    Hydrogenics Corporation (NASDAQ: HYGS) has over 60 years of experience designing, manufacturing, building and installing industrial and commercial hydrogen systems around the globe. The company offers world-leading expertise for a range of applications, including: hydrogen…

  • Highpower International (HPJ) Presents at Rodman & Renshaw Conference

    Founded in 2001 and headquartered in Shenzhen, China, Highpower International, Inc. (NASDAQ: HPJ) specializes in clean energy storage. The company is focused on the development, manufacture and marketing of Ni-MH and lithium-ion rechargeable batteries, power…

  • Hemispherx Biopharma (HEB) Presents at Rodman & Renshaw Conference

    Hemispherx Biopharma, Inc. (NYSE: HEB) is a biopharmaceutical company engaged in the manufacture and clinical development of new drug entities for treatment of viral and immune-based disorders. Hemispherx’s flagship products include Alferon N Injection and…

  • Hecla Mining Company (HL) Presents at Rodman & Renshaw Conference

    Hecla Mining Company (NYSE: HL) is the oldest precious metals mining company in North America. The company is not only the largest and one of the lowest-cost U.S. silver producers, but also a growing gold…

  • Heat Biologics (HTBX) Presents at Rodman & Renshaw Conference

    Heat Biologics, Inc. (NASDAQ: HTBX) is leading the immuno-oncology revolution. A clinical-stage company, Heat Biologics focuses on developing its proprietary “ImPACT” (Immune Pan-Antigen Cytotoxic Therapy) fully allogeneic “off-the-shelf” cell-based immunotherapy to treat patients with a…

  • Hansen Medical (HNSN) Presents at Rodman & Renshaw Conference

    Hansen Medical, Inc. (NASDAQ: HNSN), engaged in in intravascular robotics, is developing products and technology designed to enable the accurate positioning, manipulation and control of catheters and catheter-based technologies. The company’s Magellan™ Robotic System, Magellan…

  • Hansen Medical (HNSN) Presents at Rodman & Renshaw Conference

    Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, was born from the vision of creating a new generation of advanced medical robotics – a generation that would empower and protect physicians while…

  • Gulf Resources (GURE) Presents at Rodman & Renshaw Conference

    Gulf Resources, Inc. (NASDAQ: GURE) operates through two wholly-owned subsidiaries, Shouguang City Haoyuan Chemical Company Limited (“SCHC”) and ShouguangYuxin Chemical Industry Co., Limited (“SYCI”). The company believes that it is one of the largest producers…

  • Great Panther Silver (GPL) Presents at Rodman & Renshaw Conference

    Great Panther Silver Ltd. (NYSE: GPL) is a primary silver mining and exploration company whose current activities are focused on the mining of precious metals from its two whollyowned mining operations in Mexico: the Guanajuato…

  • GeoVax Labs (GOVX) Presents at Rodman & Renshaw Conference

    GeoVax Labs, Inc. (OTC: GOVX) is a clinical-stage biotechnology company developing innovative human vaccines using its novel VLP (virus-like particle) platform technology. The company’s proprietary vaccine technology has been developed through multi-year collaborations with the…

  • GenSpera (GNSZ) Presents at Rodman & Renshaw Conference

    GenSpera, Inc. (OTC: GNSZ) is a biotechnology company focused on the development and commercialization of promising, new therapeutics. GenSpera combines powerful insights and rigorous scientific methods to create new treatment options for patients. The company’s…

  • General Moly (GMO) Presents at Rodman & Renshaw Conference

    U.S.-based General Moly, Inc. (NYSE: GMO) is a mineral company engaged in the exploration, development and mining of molybdenum (”moly”). The company owns two world-class moly projects located in Nevada, U.S.; an 80% interest in…

  • Galena Biopharma (GALE) Presents at Rodman & Renshaw Conference

    Galena Biopharma, Inc. (NASDAQ: GALE) is developing and commercializing innovative, targeted oncology therapeutics that address major medical needs across the full spectrum of cancer care. Galena’s development portfolio ranges from mid- to late-stage clinical assets,…

  • Great Basin Scientific (GBSN) Presents at Rodman & Renshaw Conference

    Founded in 2005, Great Basin Scientific, Inc. (NASDAQ: GBSN) is a molecular diagnostics company commercializing breakthrough technologies that improve ease-of-use and deliver better cost per result for sample-to-result molecular diagnostic testing. The company’s breakthrough molecular…

  • Galectin Therapeutics (GALT) Presents at Rodman & Renshaw Conference

    Georgia-based Galectin Therapeutics, Inc. (NASDAQ: GALT) is a biotechnology company focused on discovery and development. The company applies its leadership in galectin science and drug development to create new therapies for fibrotic disease and cancer.…